Back to trial detailsIntake questionnaire
Fulvestrant+Abemaciclib With Run-In of Fulvestrant in Er-Positive, Her2-Negative Metastatic Breast Cancer
Applying to Houston Methodist Cancer Center · Houston, Texas
Answer a few short questions to share with the research team.
0 of 4 answered